The age of digital medicine is here!
There has never been a more pressing need for pharma to transition to digital, as existing technology starts to come into its own and newer categories begin to offer truly disruptive healthcare benefits.
As technology and traditional healthcare converge, it’s crucial we reflect on trends in cutting-edge innovation and the current state of play in digital health.
Insights derived from the right data are at the forefront of this, tying together trends in mobile health, wearables, regulatory needs and even innovative approaches to partnerships.
In addition, digital therapeutics is presenting the industry with a unique source of digital disruption and voice-activated technology is moving from the consumer realm towards the provision of digital biomarkers.
It’s evident digital therapeutics is combining high levels of innovation and personalisation with faster development than novel medicines.
Partnerships will be key to ensuring pharma makes the most of data-driven health insights.